microRNA information: hsa-miR-215-5p

SectionIDlink
Mature name: hsa-miR-215-5pmiRbase
Accession: MIMAT0000272miRbase
Precursor name: hsa-mir-215 miRbase
Precursor accession: MI0000291miRbase
Symbol: MIR215HGNC
RefSeq ID: NR_029628GenBank
Sequence: AUGACCUAUGAAUUGACAGAC



Reported expression in cancers: hsa-miR-215-5p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-215-5p

acute myeloid leukemiadownregulation"Reduced miR 215 expression predicts poor prognosis ......"26802165qPCR
hsa-miR-215-5p

breast cancerupregulation"Aberrant miR 215 expression is associated with cli ......"25270284
hsa-miR-215-5p

colon cancerderegulation"The aberrant expression of miRNA-215 miR-215 has b ......"27663660
hsa-miR-215-5p

colorectal cancerdownregulation"MicroRNA 215 inhibits relapse of colorectal cancer ......"23532818qPCR
hsa-miR-215-5p

gastric cancerupregulation"Here we report that miR-215 is significantly up-re ......"23981575
hsa-miR-215-5p

gastric cancerupregulation"However the role of miR-215 or miR-192 in gastric ......"24981590qPCR
hsa-miR-215-5p

gastric cancerupregulation"Thus the differential expression of a panel of miR ......"26171025Microarray; qPCR
hsa-miR-215-5p

gastric cancerupregulation"miR-215 was reported to be downregulated and funct ......"26716895
hsa-miR-215-5p

kidney renal cell cancerdownregulation"Here we investigated three miRNAs that are signifi ......"23715501
hsa-miR-215-5p

kidney renal cell cancerdownregulation"Conversely decreased expression of miR-106b miR-99 ......"26416448
hsa-miR-215-5p

liver cancerupregulation"Serum microRNA 143 and microRNA 215 as potential b ......"24993656qPCR
hsa-miR-215-5p

liver cancerupregulation"MicroRNA 215 is upregulated by treatment with Adri ......"26135967
hsa-miR-215-5p

lung squamous cell cancerdownregulation"MicroRNA-215 miR-215 has previously been demonstra ......"26622784qPCR
hsa-miR-215-5p

pancreatic cancerdownregulation"It has been shown that microRNA-215 miR-215 is dys ......"26662405qPCR
hsa-miR-215-5p

prostate cancerderegulation"Upregulation of miR-122 miR-335 miR-184 miR-193 mi ......"23781281
hsa-miR-215-5p

sarcomaupregulation"Further studies revealed that over-expression of m ......"20433742



Reported cancer pathway affected by hsa-miR-215-5p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-215-5p

colon cancercell cycle pathway"Prognostic significance of miR 215 in colon cancer ......"21752725
hsa-miR-215-5p

colorectal cancercell cycle pathway; Apoptosis pathway"We chose miR-215 miR-375 miR-378 miR-422a and miR- ......"22469014
hsa-miR-215-5p

colorectal cancercell cycle pathway"The CDX1 microRNA 215 axis regulates colorectal ca ......"25775580Luciferase
hsa-miR-215-5p

gastric cancercell cycle pathway; Apoptosis pathway"miR 215 promotes malignant progression of gastric ......"26716895Luciferase; Colony formation
hsa-miR-215-5p

lung squamous cell cancerApoptosis pathway"miR 215 functions as a tumor suppressor and direct ......"26622784Luciferase
hsa-miR-215-5p

ovarian cancerApoptosis pathway"miR 215 functions as a tumor suppressor in epithel ......"26676658
hsa-miR-215-5p

pancreatic cancerApoptosis pathway"MicroRNA 215 functions as a tumor suppressor and d ......"26662405Luciferase
hsa-miR-215-5p

sarcomacell cycle pathway"Molecular mechanism of chemoresistance by miR 215 ......"20433742



Reported cancer prognosis affected by hsa-miR-215-5p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-215-5p

acute myeloid leukemiaworse prognosis; poor survival"Reduced miR 215 expression predicts poor prognosis ......"26802165
hsa-miR-215-5p

breast cancermetastasis; worse prognosis; malignant trasformation; tumor size; poor survival"Aberrant miR 215 expression is associated with cli ......"25270284
hsa-miR-215-5p

breast cancermetastasis"These included miR-141 miR-144 miR-193b miR-200a m ......"26785733
hsa-miR-215-5p

cervical and endocervical cancerstaging; metastasis; progression; poor survival; recurrence"MicroRNA 215 is a potential prognostic marker for ......"24710934
hsa-miR-215-5p

colon cancerdrug resistance; poor survival; staging"Prognostic significance of miR 215 in colon cancer ......"21752725
hsa-miR-215-5p

colon cancerstaging"Using miRNA microarrays we analysed 40 paired stag ......"24239208
hsa-miR-215-5p

colon cancerstaging"Six miRNAs previously identified as prognostic mar ......"27247088
hsa-miR-215-5p

colorectal cancerstaging"We chose miR-215 miR-375 miR-378 miR-422a and miR- ......"22469014
hsa-miR-215-5p

colorectal cancerstaging"MicroRNA 215 inhibits relapse of colorectal cancer ......"23532818
hsa-miR-215-5p

colorectal cancerstaging"The Agilent Human miRNA Microarray V19.0 was used ......"25484364
hsa-miR-215-5p

colorectal cancerdifferentiation"The CDX1 microRNA 215 axis regulates colorectal ca ......"25775580Luciferase
hsa-miR-215-5p

gastric cancertumorigenesis; metastasis; worse prognosis"However the role of miR-215 or miR-192 in gastric ......"24981590
hsa-miR-215-5p

gastric cancerstaging; metastasis; differentiation"Thus the differential expression of a panel of miR ......"26171025
hsa-miR-215-5p

gastric cancermalignant trasformation; progression; metastasis; staging"miR 215 promotes malignant progression of gastric ......"26716895Luciferase; Colony formation
hsa-miR-215-5p

kidney renal cell cancermetastasis; progression"miRNA profiling in metastatic renal cell carcinoma ......"22033272
hsa-miR-215-5p

kidney renal cell cancerpoor survival"Here we investigated three miRNAs that are signifi ......"23715501Luciferase
hsa-miR-215-5p

kidney renal cell cancerworse prognosis"Conversely decreased expression of miR-106b miR-99 ......"26416448
hsa-miR-215-5p

liver cancerdrug resistance"MicroRNA 215 is upregulated by treatment with Adri ......"26135967Colony formation
hsa-miR-215-5p

lung squamous cell cancerprogression; tumorigenesis; staging; metastasis"miR 215 functions as a tumor suppressor and direct ......"26622784Luciferase
hsa-miR-215-5p

ovarian cancerdrug resistance"Analysis of microarray identified genes and microR ......"26261572
hsa-miR-215-5p

pancreatic cancerprogression; worse prognosis; staging; metastasis; poor survival; tumor size"MicroRNA 215 functions as a tumor suppressor and d ......"26662405Luciferase
hsa-miR-215-5p

sarcomadrug resistance"Molecular mechanism of chemoresistance by miR 215 ......"20433742
hsa-miR-215-5p

sarcomametastasis"This potential path highlights the crucial role of ......"25984907



Reported gene related to hsa-miR-215-5p

miRNAcancergenereportingPUBMED
hsa-miR-215-5p

colorectal cancerALCAM"Enhanced expression of CD44 CD166 and miR-21 with ......"27153478
hsa-miR-215-5p

gastric cancerALCAM"Luciferase assays suggested that microRNA-215 inhi ......"21119604
hsa-miR-215-5p

colon cancerDTL"miR-215 is a tumor suppressor candidate due to the ......"21752725
hsa-miR-215-5p

sarcomaDTL"Taken together our results indicate that miR-215 t ......"20433742
hsa-miR-215-5p

lung squamous cell cancerZEB2"miR 215 functions as a tumor suppressor and direct ......"26622784
hsa-miR-215-5p

pancreatic cancerZEB2"MicroRNA 215 functions as a tumor suppressor and d ......"26662405
hsa-miR-215-5p

colorectal cancerBMI1"In particular the miR-215 target gene BMI1 has bee ......"25775580
hsa-miR-215-5p

colorectal cancerCD44"Enhanced expression of CD44 CD166 and miR-21 with ......"27153478
hsa-miR-215-5p

colorectal cancerCDKN1A"Interestingly cell-unique downregulation of miR-22 ......"26634414
hsa-miR-215-5p

colorectal cancerCDX1"The CDX1 microRNA 215 axis regulates colorectal ca ......"25775580
hsa-miR-215-5p

sarcomaDHFR"In this study we investigated the roles of miR-215 ......"20433742
hsa-miR-215-5p

sarcomaMTX1"In this study we investigated the roles of miR-215 ......"20433742
hsa-miR-215-5p

gastric cancerRUNX1"miR 215 promotes malignant progression of gastric ......"26716895
hsa-miR-215-5p

colon cancerTP53"miR-215 is a tumor suppressor candidate due to the ......"21752725
hsa-miR-215-5p

ovarian cancerXIAP"Upregulation of miR-215 notably inhibited the expr ......"26676658
hsa-miR-215-5p

colon cancerYY1"MicroRNA 215 suppresses cell proliferation migrati ......"27663660
hsa-miR-215-5p

lung squamous cell cancerZEB2-AS1"Furthermore luciferase reporter assay analysis ide ......"26622784



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-215-5p
ANKRD6
9 cancers: BLCA; COAD; ESCA; LGG; LUAD; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.066; TCGA COAD -0.229; TCGA ESCA -0.149; TCGA LGG -0.052; TCGA LUAD -0.051; TCGA PAAD -0.076; TCGA THCA -0.094; TCGA STAD -0.127; TCGA UCEC -0.15
hsa-miR-215-5p
ARL4C
9 cancers: BLCA; CESC; COAD; ESCA; KIRP; LIHC; LUSC; PAAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.138; TCGA CESC -0.06; TCGA COAD -0.131; TCGA ESCA -0.232; TCGA KIRP -0.246; TCGA LIHC -0.11; TCGA LUSC -0.083; TCGA PAAD -0.112; TCGA STAD -0.113
hsa-miR-215-5p
C1QTNF3
11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.128; TCGA BRCA -0.224; TCGA COAD -0.228; TCGA ESCA -0.123; TCGA KIRC -0.108; TCGA KIRP -0.313; TCGA LIHC -0.374; TCGA LUAD -0.104; TCGA LUSC -0.135; TCGA STAD -0.176; TCGA UCEC -0.141
hsa-miR-215-5p
CLIP4
14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.244; TCGA CESC -0.232; TCGA COAD -0.245; TCGA ESCA -0.301; TCGA HNSC -0.072; TCGA KIRC -0.109; TCGA LGG -0.058; TCGA LIHC -0.25; TCGA LUAD -0.065; TCGA LUSC -0.138; TCGA PAAD -0.161; TCGA THCA -0.115; TCGA STAD -0.23; TCGA UCEC -0.139
hsa-miR-215-5p
CLSTN1
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; THCA
miRNAWalker2 validate
TCGA BLCA -0.076; TCGA BRCA -0.067; TCGA CESC -0.084; TCGA ESCA -0.104; TCGA HNSC -0.091; TCGA KIRC -0.066; TCGA KIRP -0.069; TCGA LIHC -0.101; TCGA LUSC -0.134; TCGA THCA -0.065
hsa-miR-215-5p
CORO2B
9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.114; TCGA CESC -0.162; TCGA COAD -0.245; TCGA ESCA -0.082; TCGA KIRC -0.3; TCGA LIHC -0.123; TCGA PAAD -0.212; TCGA STAD -0.122; TCGA UCEC -0.345
hsa-miR-215-5p
DNAJB5
12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; PAAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.252; TCGA CESC -0.119; TCGA COAD -0.213; TCGA ESCA -0.228; TCGA HNSC -0.143; TCGA LGG -0.058; TCGA LIHC -0.079; TCGA PAAD -0.147; TCGA SARC -0.149; TCGA THCA -0.148; TCGA STAD -0.286; TCGA UCEC -0.172
hsa-miR-215-5p
FGF2
9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LIHC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.235; TCGA COAD -0.2; TCGA ESCA -0.105; TCGA KIRC -0.156; TCGA KIRP -0.272; TCGA LIHC -0.153; TCGA THCA -0.114; TCGA STAD -0.156; TCGA UCEC -0.327
hsa-miR-215-5p
FZD1
10 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.051; TCGA CESC -0.088; TCGA COAD -0.071; TCGA ESCA -0.139; TCGA KIRP -0.109; TCGA LUAD -0.127; TCGA LUSC -0.096; TCGA PAAD -0.067; TCGA STAD -0.074; TCGA UCEC -0.098
hsa-miR-215-5p
HSPA2
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.09; TCGA BRCA -0.186; TCGA CESC -0.176; TCGA COAD -0.122; TCGA ESCA -0.239; TCGA KIRC -0.527; TCGA LIHC -0.07; TCGA STAD -0.213; TCGA UCEC -0.149
hsa-miR-215-5p
IGF1R
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.142; TCGA BRCA -0.089; TCGA CESC -0.171; TCGA COAD -0.097; TCGA ESCA -0.168; TCGA PAAD -0.154; TCGA THCA -0.062; TCGA STAD -0.126; TCGA UCEC -0.113
hsa-miR-215-5p
KCTD15
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.138; TCGA BRCA -0.112; TCGA CESC -0.221; TCGA ESCA -0.266; TCGA HNSC -0.104; TCGA LIHC -0.101; TCGA LUSC -0.136; TCGA PAAD -0.078; TCGA STAD -0.185; TCGA UCEC -0.23
hsa-miR-215-5p
MCAM
10 cancers: BLCA; CESC; COAD; LIHC; LUAD; PAAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.107; TCGA CESC -0.233; TCGA COAD -0.087; TCGA LIHC -0.119; TCGA LUAD -0.055; TCGA PAAD -0.096; TCGA SARC -0.167; TCGA THCA -0.192; TCGA STAD -0.149; TCGA UCEC -0.156
hsa-miR-215-5p
MSN
9 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; PAAD; THCA; STAD
miRNAWalker2 validate; MirTarget
TCGA BLCA -0.172; TCGA CESC -0.245; TCGA COAD -0.148; TCGA ESCA -0.217; TCGA LIHC -0.067; TCGA LUAD -0.102; TCGA PAAD -0.081; TCGA THCA -0.221; TCGA STAD -0.106
hsa-miR-215-5p
NT5M
11 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LGG; LUAD; PAAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.139; TCGA BRCA -0.13; TCGA ESCA -0.15; TCGA KIRC -0.089; TCGA KIRP -0.083; TCGA LGG -0.087; TCGA LUAD -0.061; TCGA PAAD -0.169; TCGA SARC -0.154; TCGA STAD -0.11; TCGA UCEC -0.072
hsa-miR-215-5p
PDLIM3
9 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.408; TCGA CESC -0.233; TCGA COAD -0.279; TCGA ESCA -0.186; TCGA LIHC -0.12; TCGA LUAD -0.052; TCGA SARC -0.283; TCGA STAD -0.26; TCGA UCEC -0.499
hsa-miR-215-5p
PLAU
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; THCA
miRNAWalker2 validate
TCGA BLCA -0.187; TCGA BRCA -0.081; TCGA CESC -0.227; TCGA ESCA -0.195; TCGA HNSC -0.235; TCGA KIRC -0.225; TCGA LIHC -0.138; TCGA LUAD -0.167; TCGA LUSC -0.224; TCGA PAAD -0.125; TCGA THCA -0.432
hsa-miR-215-5p
PLS3
9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.13; TCGA CESC -0.097; TCGA COAD -0.098; TCGA ESCA -0.148; TCGA HNSC -0.059; TCGA KIRC -0.17; TCGA LUAD -0.139; TCGA THCA -0.068; TCGA STAD -0.089
hsa-miR-215-5p
PRICKLE1
13 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.245; TCGA CESC -0.256; TCGA COAD -0.333; TCGA ESCA -0.255; TCGA KIRC -0.118; TCGA KIRP -0.149; TCGA LGG -0.063; TCGA LUAD -0.101; TCGA LUSC -0.137; TCGA PAAD -0.207; TCGA THCA -0.219; TCGA STAD -0.162; TCGA UCEC -0.295
hsa-miR-215-5p
PRNP
11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.206; TCGA CESC -0.218; TCGA COAD -0.118; TCGA ESCA -0.231; TCGA HNSC -0.135; TCGA LUAD -0.062; TCGA LUSC -0.157; TCGA PAAD -0.113; TCGA THCA -0.052; TCGA STAD -0.208; TCGA UCEC -0.211
hsa-miR-215-5p
PRSS23
9 cancers: BLCA; BRCA; COAD; HNSC; PAAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.13; TCGA BRCA -0.203; TCGA COAD -0.15; TCGA HNSC -0.137; TCGA PAAD -0.073; TCGA SARC -0.155; TCGA THCA -0.321; TCGA STAD -0.134; TCGA UCEC -0.192
hsa-miR-215-5p
RAB23
11 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.212; TCGA CESC -0.067; TCGA COAD -0.136; TCGA ESCA -0.077; TCGA KIRC -0.055; TCGA LIHC -0.071; TCGA LUAD -0.054; TCGA LUSC -0.058; TCGA PAAD -0.067; TCGA STAD -0.212; TCGA UCEC -0.223
hsa-miR-215-5p
RADIL
9 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LUAD; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.154; TCGA CESC -0.125; TCGA ESCA -0.302; TCGA KIRC -0.092; TCGA KIRP -0.232; TCGA LUAD -0.132; TCGA PAAD -0.171; TCGA STAD -0.217; TCGA UCEC -0.327
hsa-miR-215-5p
RHOBTB3
9 cancers: BLCA; CESC; KIRC; LGG; LUAD; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.08; TCGA CESC -0.109; TCGA KIRC -0.361; TCGA LGG -0.054; TCGA LUAD -0.103; TCGA PAAD -0.172; TCGA THCA -0.169; TCGA STAD -0.094; TCGA UCEC -0.173
hsa-miR-215-5p
SLCO3A1
9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; PAAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.121; TCGA CESC -0.095; TCGA COAD -0.113; TCGA ESCA -0.137; TCGA KIRC -0.087; TCGA LIHC -0.074; TCGA LUAD -0.091; TCGA PAAD -0.102; TCGA STAD -0.112
hsa-miR-215-5p
TMEM200B
9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; SARC; UCEC
miRNAWalker2 validate
TCGA BLCA -0.203; TCGA CESC -0.189; TCGA COAD -0.293; TCGA ESCA -0.259; TCGA HNSC -0.242; TCGA LUAD -0.109; TCGA LUSC -0.139; TCGA SARC -0.26; TCGA UCEC -0.412
hsa-miR-215-5p
TRIM23
10 cancers: BLCA; CESC; COAD; ESCA; LGG; LUAD; PAAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.071; TCGA CESC -0.055; TCGA COAD -0.076; TCGA ESCA -0.053; TCGA LGG -0.066; TCGA LUAD -0.064; TCGA PAAD -0.092; TCGA SARC -0.06; TCGA STAD -0.103; TCGA UCEC -0.123
hsa-miR-215-5p
TRPC1
12 cancers: BLCA; COAD; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.074; TCGA COAD -0.245; TCGA ESCA -0.125; TCGA KIRP -0.135; TCGA LGG -0.09; TCGA LIHC -0.186; TCGA LUAD -0.09; TCGA LUSC -0.11; TCGA PAAD -0.162; TCGA SARC -0.09; TCGA STAD -0.209; TCGA UCEC -0.314
hsa-miR-215-5p
WWC3
11 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.128; TCGA CESC -0.104; TCGA COAD -0.134; TCGA ESCA -0.145; TCGA LIHC -0.122; TCGA LUAD -0.095; TCGA LUSC -0.074; TCGA PAAD -0.066; TCGA THCA -0.085; TCGA STAD -0.15; TCGA UCEC -0.115
hsa-miR-215-5p
KCNMB4
9 cancers: BRCA; CESC; COAD; ESCA; KIRC; LIHC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.121; TCGA CESC -0.243; TCGA COAD -0.247; TCGA ESCA -0.114; TCGA KIRC -0.099; TCGA LIHC -0.118; TCGA PAAD -0.2; TCGA STAD -0.194; TCGA UCEC -0.149
hsa-miR-215-5p
SYNGR1
11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.093; TCGA CESC -0.169; TCGA COAD -0.235; TCGA ESCA -0.233; TCGA KIRC -0.248; TCGA KIRP -0.163; TCGA LGG -0.059; TCGA LIHC -0.193; TCGA LUSC -0.122; TCGA PAAD -0.144; TCGA UCEC -0.154
hsa-miR-215-5p
MEX3B
9 cancers: CESC; COAD; ESCA; KIRP; LGG; LIHC; LUAD; STAD; UCEC
miRNAWalker2 validate
TCGA CESC -0.104; TCGA COAD -0.087; TCGA ESCA -0.158; TCGA KIRP -0.052; TCGA LGG -0.127; TCGA LIHC -0.104; TCGA LUAD -0.052; TCGA STAD -0.115; TCGA UCEC -0.245
hsa-miR-215-5p
MTSS1
11 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA CESC -0.408; TCGA ESCA -0.314; TCGA HNSC -0.095; TCGA KIRC -0.054; TCGA KIRP -0.111; TCGA LGG -0.086; TCGA LUSC -0.168; TCGA PAAD -0.079; TCGA THCA -0.156; TCGA STAD -0.13; TCGA UCEC -0.149
hsa-miR-215-5p
NPHP3
9 cancers: CESC; COAD; ESCA; KIRP; LIHC; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA CESC -0.063; TCGA COAD -0.057; TCGA ESCA -0.055; TCGA KIRP -0.096; TCGA LIHC -0.066; TCGA LUSC -0.077; TCGA PAAD -0.059; TCGA STAD -0.087; TCGA UCEC -0.086
hsa-miR-215-5p
PHTF2
10 cancers: CESC; ESCA; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA CESC -0.061; TCGA ESCA -0.105; TCGA KIRP -0.06; TCGA LIHC -0.094; TCGA LUAD -0.072; TCGA LUSC -0.054; TCGA PAAD -0.123; TCGA SARC -0.079; TCGA STAD -0.104; TCGA UCEC -0.079





Enriched cancer pathways of putative targets